Page last updated: 2024-09-02

valerates and concanavalin a

valerates has been researched along with concanavalin a in 5 studies

Compound Research Comparison

Studies
(valerates)
Trials
(valerates)
Recent Studies (post-2010)
(valerates)
Studies
(concanavalin a)
Trials
(concanavalin a)
Recent Studies (post-2010) (concanavalin a)
2,25129445717,959821,337

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aeed, H; Bruck, R; Greenspoon, N; Halpern, Z; Hershkoviz, R; Lider, O1
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Kenet, G; Lider, O; Matas, Z; Shirin, H; Zaidel, L1
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H1
Fuller, JC; Nissen, S; Ostaszewski, P; Siwicki, AK; Studnicka, M1
Calder, PC; Fernandes, LC; Lomax, AR; Miles, EA; Noakes, PS; Nunes, EA1

Reviews

1 review(s) available for valerates and concanavalin a

ArticleYear
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
    The Israel Medical Association journal : IMAJ, 2000, Volume: 2 Suppl

    Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates

2000

Other Studies

4 other study(ies) available for valerates and concanavalin a

ArticleYear
Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope.
    Journal of hepatology, 1995, Volume: 22, Issue:2

    Topics: Animals; Cell Adhesion; Concanavalin A; Epitopes; Extracellular Matrix; Fibronectins; Guanidines; Immunity, Cellular; Laminin; Liver; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Oligopeptides; Receptors, Immunologic; T-Lymphocytes; Valerates

1995
Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
    Gut, 1997, Volume: 40, Issue:1

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Concanavalin A; Guanidines; Hepatitis, Animal; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha; Valerates

1997
In vitro effects of beta-hydroxy-beta-methylbutyrate (HMB) on cell-mediated immunity in fish.
    Veterinary immunology and immunopathology, 2000, Oct-31, Volume: 76, Issue:3-4

    Topics: Animals; Carps; Cell Division; Concanavalin A; Formazans; Immunity, Cellular; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Oncorhynchus mykiss; Phagocytes; Phagocytosis; Respiratory Burst; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Valerates

2000
β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro.
    Nutrition (Burbank, Los Angeles County, Calif.), 2011, Volume: 27, Issue:1

    Topics: Adult; Cell Cycle; Cell Proliferation; Concanavalin A; Cytokines; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunologic Factors; Interleukin-2 Receptor alpha Subunit; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Th1 Cells; Th1-Th2 Balance; Th2 Cells; Tumor Necrosis Factor-alpha; Valerates; Young Adult

2011